Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia: A Multinational Discrete Choice Experiment
Samantha Nier, Hannah Hussain, Jake Hitch, Sulayman Chowdhury, Chris Skedgel, David John Mott · 2026
Read Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia: A Multinational Discrete Choice Experiment by Samantha Nier, Hannah Hussain, Jake Hitch, Sulayman Chowdhury, Chris Skedgel, David John Mott (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13271056.txt.
Description
Samantha Nier is lead author of a 2026 multinational study of treatment preferences in relapsed or refractory acute leukaemia, a fast-moving white blood cell cancer that has returned or resisted first treatment. Using a web-based choice experiment, patients picked between imagined treatments that differed in benefit, side effects, and delivery.
In total, 267 adults in the United Kingdom, United States, France, Germany, and Italy took part. Chance of response dominated, carrying 62 percent of the decision weight, followed by quality of life during response at 14 percent. Three preference groups appeared: nearly half focused mainly on effectiveness, while others balanced convenience or all features more evenly.
Catalog record
| CREATOR | Samantha Nier, Hannah Hussain, Jake Hitch, Sulayman Chowdhury, Chris Skedgel, David John Mott |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34971 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |